Schnitzler Syndrome: Insights into Its Pathogenesis, Clinical Manifestations, and Current Management.
NLRP3 inflammasome
Schnitzler syndrome
anakinra
autoinflammation
interleukin 1-beta
monoclonal gammopathy
Journal
Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414
Informations de publication
Date de publication:
31 May 2024
31 May 2024
Historique:
received:
07
05
2024
revised:
26
05
2024
accepted:
28
05
2024
medline:
27
6
2024
pubmed:
27
6
2024
entrez:
27
6
2024
Statut:
epublish
Résumé
Schnitzler syndrome is a rare disorder characterized by a chronic urticarial rash associated with immunoglobulin M (IgM) monoclonal gammopathy. Schnitzler syndrome shares strong clinicopathologic similarities with monogenic IL-1-mediated autoinflammatory disorders and is now considered an acquired adult-onset autoinflammatory disease. The spectacular effect of interleukin-1 inhibitors demonstrates the key role of this cytokine in the pathogenesis of the disease. However, the physiopathology of Schnitzler syndrome remains elusive, and the main question regarding the relationship between autoinflammatory features and monoclonal gammopathy is still unanswered. The purpose of this narrative review is to describe what is currently known about the pathogenesis of this peculiar disease, as well as to address its diagnosis and management.
Identifiants
pubmed: 38927050
pii: biom14060646
doi: 10.3390/biom14060646
pii:
doi:
Substances chimiques
Immunoglobulin M
0
Interleukin-1
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM